Mathematical Modeling of HCV Viral Kinetics
نویسندگان
چکیده
Hepatitis C virus (HCV) is a single-stranded RNA virus that infects the hepatocytes of the liver. Infected cells become damaged and release alanine aminotransferase (ALT), which exists normally within liver cells. Our main goal in this project was to determine the usefullness of ALT levels to determine the outcome of HCV treatment and viral load levels. As part of our investigations, we first looked for correlations between ALT levels and viral load in order to examine the hypothesis that ALT levels could have the capability to estimate viral load. Since we did not have quantitative viral load data, we created a mathematical model and simulated data to test these correlations. Next, we created boxplots for each month of our simulated and collected ALT data to observe the differences in their distributions over time. This was also to determine whether or not our simulated data could be useful in drawing conclusions about how ALT levels and viral load are correlated in reality. The next objective was to use principal component analysis to identify the principal components responsible for the most significant portion of variation in the data. Finally, the simulated data was generated for different longitudinal schedules of observation to compare the parameter estimates and standard errors. By doing this, we were able to suggest alternative time points for which to collect data that would allow more efficient estimation of parameters in the future.
منابع مشابه
HCV Kinetic Models and Their Implications in Drug Development
Chronic infection with hepatitis C virus (HCV) affects about 170 million people worldwide and is a major cause of liver complications. Mathematical modeling of viral kinetics under treatment has provided insight into the viral life cycle, treatment effectiveness, and drugs' mechanisms of action. Here we review the implications of viral kinetic models at the different stages of development of an...
متن کاملMathematical modeling: a tool for selecting agents with complementary modes of action?
The nonstructural 5A (NS5A) protein is a target for drug development against hepatitis C virus (HCV). Interestingly, the NS5A inhibitor daclatasvir (BMS-790052) caused a decrease in serum HCV RNA levels by about two orders of magnitude within 6 h of administration. However, NS5A has no known enzymatic functions, making it difficult to understand daclatasvir’s mode of action (MOA) and to estimat...
متن کاملMathematical Model of Viral Kinetics In Vitro Estimates the Number of E2-CD81 Complexes Necessary for Hepatitis C Virus Entry
Interaction between the hepatitis C virus (HCV) envelope protein E2 and the host receptor CD81 is essential for HCV entry into target cells. The number of E2-CD81 complexes necessary for HCV entry has remained difficult to estimate experimentally. Using the recently developed cell culture systems that allow persistent HCV infection in vitro, the dependence of HCV entry and kinetics on CD81 expr...
متن کاملModeling subgenomic hepatitis C virus RNA kinetics during treatment with alpha interferon.
Although replicons have been used to demonstrate hepatitis C virus (HCV) inhibition by alpha interferon (IFN-alpha), the detailed inhibition kinetics required to mathematically model HCV RNA decline have been lacking. Therefore, we measured genotype 1b subgenomic replicon (sg1b) RNA levels under various IFN-alpha concentrations to assess the inhibition kinetics of intracellular HCV RNA. During ...
متن کاملHCV kinetic and modeling analyses project shorter durations to cure under combined therapy with daclatasvir and asunaprevir in chronic HCV-infected patients
BACKGROUND & AIMS High cure rates are achieved in HCV genotype-1b patients treated with daclatasvir and asunaprevir, DCV/ASV. Here we analyzed early HCV kinetics in genotype-1b infected Japanese subjects treated with DCV/ASV and retrospectively projected, using mathematical modeling, whether shorter treatment durations might be effective. METHODS HCV RNA levels were measured frequently during...
متن کاملImprovement of ALT decay kinetics by all-oral HCV treatment: Role of NS5A inhibitors and differences with IFN-based regimens
BACKGROUND Intracellular HCV-RNA reduction is a proposed mechanism of action of direct-acting antivirals (DAAs), alternative to hepatocytes elimination by pegylated-interferon plus ribavirin (PR). We modeled ALT and HCV-RNA kinetics in cirrhotic patients treated with currently-used all-DAA combinations to evaluate their mode of action and cytotoxicity compared with telaprevir (TVR)+PR. STUDY ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2013